Breast Cancer Screening Trials: Endpoints and Overdiagnosis

Medicine and Dentistry

• Breast Cancer 100%
• Screening 83%
• Overdiagnosis 83%
• Neoplasm 50%
• Mortality 50%
• Cancer Diagnosis 33%
• Metastatic Carcinoma 16%
• Magnetic Resonance Imaging 16%
• Morbidity 16%
• Mammography 16%
• Malignant Neoplasm 16%
• Intraductal Carcinoma 16%
• Deterioration 16%
• Cancer Mortality 16%
• Tumor Invasion 16%
• Digital Breast Tomosynthesis 16%
• Therapeutic Procedure 16%
• Absence 16%
• Health Care 16%
• Quality of Life 16%
• Anxiety 16%
• Patient 16%

Biochemistry, Genetics and Molecular Biology

• Screening 83%
• Breast Cancer Screening 66%
• Mortality 50%
• Morbidity 16%
• Ultrasound 16%
• Cancer Mortality 16%
• Contrast 16%
• Reduction (Chemistry) 16%
• Life 16%
• Health 16%
• Anxiety 16%
• Magnetic Resonance Imaging 16%